Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hikma Pharmaceuticals Plc (OP: HKMPF )

25.25 +0.32 (+1.30%)
Streaming Delayed Price Updated: 12:57 PM EDT, Jun 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hikma Pharmaceuticals Plc

Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape
The FDA is actively seeking new suppliers to address the shortages of methotrexate, a widely used cancer drug in short supply since March.  Methotrexate is an injected medication utilized to treat... 
Via Benzinga
Week In Review: Ten Biggest 2022 China Biopharma Deals Worth $21.5 Billion
China Biopharma deal activity in 2022 was certainly slower than the previous year, but the ten largest deals, many of them booked in the second half of the year, totaled a decent $21.5 billion by... 
Via Talk Markets
Up On Bad News
Despite the plane crash in China, Boeing's stock is up today. 
Via Talk Markets
A Peek Into The Markets: US Stock Futures Mostly Higher; Crude Oil Rises Over 1%
Pre-open movers U.S. stock futures traded mostly higher in early pre-market trade after recording a slight gain in the previous session. Investors are awaiting earnings results... 
Via Benzinga
Exposures Fossil Fuels
Hikma Bolsters Injectable Portfolio With $375M Custopharm Acquisition
Hikma Pharmaceuticals Plc (OTC: HKMPF) has agreed to acquire US-based generic sterile injectables producer Custopharm Inc from Water Street... 
Via Benzinga
Wonder Products
Meme is alive and well. 
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.